The New York Times reports on a new study confirming that hard-to-cure drug-resistant tuberculosis is a growing problem.

Reuters covers the alarming numbers of drug-resistant tuberculosis that exist in Africa, Asia, Europe and Latin America.

Aeras Chief Scientific Officer Tom Evans responds to study published in The Lancet: “Prevalence of and risk factors for resistance to second-line drugs in people with multi-drug resistant tuberculosis in eight countries

Hoosen Coovadia blogs about the risk of TB for healthcare workers in South Africa, and the need for new vaccines to protect them.

Professor Helen McShane of the University of Oxford writes about the beginning of the largest TB vaccine clinical trial in 90 years for the Royal Society of Medicine's Reports in Global Health.